-
Nature: New target for Alzheimer's disease, Nanjing University Li Liang/Zeng Ke's team reveals
Time of Update: 2021-04-19
On April 1, 2021, Liang Li/Zeng Ke's research group from the School of Life Sciences, Nanjing University published a research paper titled Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration in the journal Nature Communications.
-
Nature | Clinical Trial Results of Vaccine Targeting IDH1 Mutant Glioma
Time of Update: 2021-04-19
Recently, the Michael Platten research group from the German Cancer Research Center published an article titled A vaccine targeting mutant IDH1 in newly diagnosed glioma in the journal Nature.
-
Nature: Bacterial peptides on the surface of tumor cells are expected to become a new target for cancer immunotherapy
Time of Update: 2021-03-27
com" target="_blank">/---Cancer immunotherapy may be promoted in an unexpected direction: bacteria residing in tumor cells.
-
Two new breakthroughs in Nature's anti-cancer: new epigenetic target-NSD3
Time of Update: 2021-03-26
Recently, two papers published in the journal Nature[1][2] showed that the enzyme NSD3 that controls the addition of this marker has been mutated in some human cancers and has become extremely active.
-
Nature In-depth Report: CAR-T therapy breakthroughs continue to be the most promising of these new targets
Time of Update: 2021-03-23
More clinical studies are evaluating whether mesothelin-targeted CAR-T cell therapy can enhance T cell responses by combining immune checkpoint blockade.
-
Nature Biomedical Engineering: New nanoparticles can be targeted to treat tumors
Time of Update: 2021-02-24
Cholka, Yang-xin Fu, Baran D. Sumer, Hongtao Yu, Jinming Gao. Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nature Biomedical Engineering, 2021; DOI: 10.1038/s41551-020-00675-9MedSci Original Source: MedSci Original
-
Nature's latest report reveals: 4 popular target organs, TOP10 adaptation certificate
Time of Update: 2021-02-23
based on an analysis of clinical data from more than 3,000 patients over 20 years, the authors believe that AAV gene therapy is a safe, well-to-use and effective treatment.
-
Arjuna Natural targets energy bar market with genus plant extracts
Time of Update: 2021-02-07
Arjuna 's production process extracts the right level of nitrate from the leaves of the genus plant: 9 grams per 100 grams, higher than beetroot powder and beet juice.
-
Nature sub-journal paper details! CAR-T cells targeting CXCR5 are expected to treat feliestic lymphoma and chronic lymphocytic leukemia
Time of Update: 2021-01-27
easy to control. a clinical trial in progress, Hoepken stressed, "No laboratory can do such research alone." thanks to the successful collaboration of many colleagues at max-delbruck Molecular Medical Center and Berlin's Schalette School
-
Nature sub-journal interpretation! Scientists are expected to develop a new drug discovery strategy for "drug-free" drug targets!
Time of Update: 2021-01-12
